Skip Nav Destination
            
    
            
 
    
    
        
            
                
                
                    
                    
                        
                    
                
                
                    
                        
                        
                            
                        
                    
            
        
    
    
    
    
        
            
        
        
    
        
    
    
    
 
    
                
                    
            
    
        
    
    
                    
                    
        
        Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance 
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                    
        
                    
        
        Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                    
        
                    
        
        Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                    
        
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
                
            
    
    
    
        
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
        
        Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
        
        
            
        
    
        
                
            
    
    
    
        
                    
                
            
    
    
    
        
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
                
            
    
    
    
        
                    
                
            
    
    
    
        
        
     
    
                    
        
        
                    
        
        Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                    
        
                    
                
            
    
    
    
        
        
                    
                
            
    
    
    
        
        
     
    
                    
        
                    
        
        Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted
        
        
            
        
    
        
                
            
    
    
    
        
                    
        
        Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
 
    
            
    
        
    
         
 
    
    
        
    
            
    
        
    
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
    
        
    
    
    
            
        
            
    
        
        
    
             
            
             
            
             
        
    
 
    
    
 
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
 
    
    
    
    
        
    Issue Archive
Table of Contents
EXCEPTIONAL CASE REPORT
        
        Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance 
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Justin Anthony Chen,Yanli Hou,Krishna M. Roskin,Daniel A. Arber,Charles D. Bangs,Linda B. Baughn,Athena M. Cherry,Mark D. Ewalt,Andrew Z. Fire,Laure Fresard,Hutton M. Kearney,Stephen B. Montgomery,Robert S. Ohgami,Kathryn E. Pearce,Beth A. Pitel,Jason D. Merker,Jason Gotlib
            
        
    
            STIMULUS REPORT
        
        Germline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Miriam Elbracht,Robert Meyer,Kim Kricheldorf,Deniz Gezer,Eggermann Thomas,Beate Betz,Ingo Kurth,Lino L. Teichmann,Tim H. Brümmendorf,Ulrich Germing,Susanne Isfort,Steffen Koschmieder
            
        
    
            SYSTEMATIC REVIEW
CLINICAL TRIALS AND OBSERVATIONS
        
        Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Isabelle A. van Zeventer,Aniek O. de Graaf,Melanie M. van der Klauw,Edo Vellenga,Bert A. van der Reijden,Jan Jacob Schuringa,Arjan Diepstra,Luca Malcovati,Joop H. Jansen,Gerwin Huls
            
        
    
            
        
        Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Christian Buske,Wojciech Jurczak,Juan-Manuel Sancho,Edvard Zhavrid,Jin Seok Kim,José-Ángel Hernández-Rivas,Aliaksandr Prokharau,Mariana Vasilica,Rajnish Nagarkar,Larry Kwak,Won-Seog Kim,SangJoon Lee,SungHyun Kim,KeumYoung Ahn,Michinori Ogura
            
        
    
            
        
        Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Alex F. Herrera,Catherine Burton,John Radford,Fiona Miall,William Townsend,Armando Santoro,Pier Luigi Zinzani,David Lewis,Camilla Fowst,Satjit Brar,Bo Huang,Aron Thall,Graham P. Collins
            
        
    
            
        
        Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Hasmukh Jain,Manju Sengar,Vasu Babu Goli,Jayashree Thorat,Prashant Tembhare,Dhanlaxmi Shetty,V. N. Avinash Bonda,Lingaraj Nayak,P. G. Subramanian,Bhausaheb Bagal,Nikhil Patkar,Neha Sharma,Himanshi Gupta,Sumeet Gujral
            
        
    
            GENE THERAPY
Identification of coagulation factor IX variants with enhanced activity through ancestral sequence reconstruction
            Kristopher A. Knight,Christopher W. Coyle,Caelan E. Radford,Ernest T. Parker,Andrew Fedanov,Jordan M. Shields,Fania Szlam,Anatolii Purchel,Michelle Chen,Gabriela Denning,Roman M. Sniecinski,Pete Lollar,H. Trent Spencer,Eric A. Gaucher,Christopher B. Doering
            
        
    
            HEMATOPOIESIS AND STEM CELLS
Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18INK4C
            Yinghui Li,Wenshan Zhang,Yu Zhang,Yahui Ding,Ming Yang,Mei He,Xiaolei Liu,Jiali Gu,Shiqi Xu,Zhiwei Feng,Yafang Li,Jingjing Yin,Huier Gao,Henan Song,Hui Xu,Chaoqun Wang,Qing Ji,Shihui Ma,Wanzhu Yang,Weiping Yuan,Xiang-Qun Xie,Tao Cheng,Yingdai Gao
            
        
    
            Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation
            Rima M. Saliba,Uri Greenbaum,Qing Ma,Samer A. Srour,Yudith Carmazzi,Liang Li,Betul Oran,Michael Moller,Janet Wood,Stefan O. Ciurea,Piyanuch Kongtim,Gabriela Rondon,David Partlow,Dan Li,Katayoun Rezvani,Elizabeth J. Shpall,Kai Cao,Richard E. Champlin,Jun Zou
            
        
    
            IMMUNOBIOLOGY AND IMMUNOTHERAPY
        
        Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Kent P. Jensen,David A. Hongo,XuHuai Ji,PingPing Zheng,Rahul D. Pawar,Thomas Hsin-Hsu Wu,Stephan Busque,John D. Scandling,Judith A. Shizuru,Robert Lowsky,Asha Shori,Suparna Dutt,Jeffrey Waters,Anirudh Saraswathula,Jeanette Baker,John S. Tamaresis,Philip Lavori,Robert Negrin,Holden Maecker,Edgar G. Engleman,Everett Meyer,Samuel Strober
            
        
    
            
        
        Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Martina Pennisi,Miriam Sanchez-Escamilla,Jessica R. Flynn,Roni Shouval,Ana Alarcon Tomas,Mari Lynn Silverberg,Connie Batlevi,Renier J. Brentjens,Parastoo B. Dahi,Sean M. Devlin,Claudia Diamonte,Sergio Giralt,Elizabeth F. Halton,Tania Jain,Molly Maloy,Elena Mead,Maria Lia Palomba,Josel Ruiz,Bianca Santomasso,Craig S. Sauter,Michael Scordo,Gunjan L. Shah,Jae H. Park,Lucrecia Yanez San Segundo,Miguel-Angel Perales
            
        
    
            Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease
            Sheila K. Pierson,Sushila Shenoy,Ana B. Oromendia,Alexander M. Gorzewski,Ruth-Anne Langan Pai,Christopher Shield Nabel,Jason R. Ruth,Sophia A. T. Parente,Daniel J. Arenas,Mary Guilfoyle,Manjula Reddy,Michael Weinblatt,Nancy Shadick,Mark Bower,Alessia Dalla Pria,Yasufumi Masaki,Laura Katz,Jason Mezey,Philip Beineke,David Lee,Craig Tendler,Taku Kambayashi,Alexander Fosså,Frits van Rhee,David C. Fajgenbaum
            
        
    
            IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
            Howard Lin,Brooks P. Scull,Baruch R. Goldberg,Harshal A. Abhyankar,Olive E. Eckstein,Daniel J. Zinn,Joseph Lubega,Jennifer Agrusa,Nader El Mallawaney,Nitya Gulati,Lisa Forbes,Ivan Chinn,Rikhia Chakraborty,Jessica Velasquez,Jordana Goldman,Dalia Bashir,Fong Lam,Eyal Muscal,Michael. M. Henry,Jay N. Greenberg,Stephan Ladisch,Michelle L. Hermiston,Lauren K. Meyer,Michael Jeng,Ahmed Naqvi,Kenneth McClain,Trung Nguyen,Hector Wong,Tsz-Kwong Man,Michael B. Jordan,Carl E. Allen
            
        
    
            LYMPHOID NEOPLASIA
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial
            Rachel J. Mitchell,Amy A. Kirkwood,Emilio Barretta,Laura Clifton-Hadley,Emma Lawrie,SooWah Lee,Daniel Leongamornlert,David I. Marks,Andrew K. McMillan,Tobias F. Menne,Elli Papaemmanuil,Bela Patel,Pip Patrick,Clare J. Rowntree,Nahid Zareian,Krisztina Zuborne Alapi,Anthony V. Moorman,Adele K. Fielding
            
        
    
            Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL
            Kallesh D. Jayappa,Vicki L. Gordon,Christopher G. Morris,Briana Wilson,B. Dharmaveer Shetty,Konrad J. Cios,Puja C. Arora,Krista M. Isaac,Shekhar Saha,Timothy P. Bender,Michael E. Williams,Craig A. Portell,Michael J. Weber
            
        
    
            MYELOID NEOPLASIA
        
        Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Inge van der Werf,Anna Wojtuszkiewicz,Manja Meggendorfer,Stephan Hutter,Constance Baer,Martijn Heymans,Peter J. M. Valk,Wolfgang Kern,Claudia Haferlach,Jeroen J. W. M. Janssen,Gert J. Ossenkoppele,Jacqueline Cloos,Torsten Haferlach
            
        
    
            
        
        Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Sebastian Stasik,Jan-Niklas Eckardt,Michael Kramer,Christoph Röllig,Alwin Krämer,Sebastian Scholl,Andreas Hochhaus,Martina Crysandt,Tim H. Brümmendorf,Ralph Naumann,Björn Steffen,Volker Kunzmann,Hermann Einsele,Markus Schaich,Andreas Burchert,Andreas Neubauer,Kerstin Schäfer-Eckart,Christoph Schliemann,Stefan Krause,Regina Herbst,Mathias Hänel,Norbert Frickhofen,Richard Noppeney,Ulrich Kaiser,Claudia D. Baldus,Martin Kaufmann,Zdenek Rácil,Uwe Platzbecker,Wolfgang E. Berdel,Jiri Mayer,Hubert Serve,Carsten Müller-Tidow,Gerhard Ehninger,Martin Bornhäuser,Johannes Schetelig,Jan M. Middeke,Christian Thiede,on behalf of the Study Alliance Leukemia (SAL)
            
        
    
            THROMBOSIS AND HEMOSTASIS
Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura
            Kadri Kangro,Elien Roose,Bérangère S. Joly,György Sinkovits,Tanja Falter,Charis von Auer,Heidi Rossmann,Marienn Reti,Jan Voorberg,Zoltán Prohászka,Bernhard Lämmle,Paul Coppo,Agnès Veyradier,Simon F. De Meyer,Andres Männik,Karen Vanhoorelbeke
            
        
    
            Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis
            Derek J. B. Kleinveld,Derek D. G. Simons,Charlotte Dekimpe,Shannen J. Deconinck,Pieter H. Sloos,M. Adrie W. Maas,Jesper Kers,Joshua Muia,Karim Brohi,Jan Voorberg,Karen Vanhoorelbeke,Markus W. Hollmann,Nicole P. Juffermans,on behalf of BloodNet
            
        
    
            TRANSPLANTATION
        
        Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Jeremy D. Rubinstein,Xiang Zhu,Thomas Leemhuis,Giang Pham,Lorraine Ray,Sana Emberesh,Sonata Jodele,Shawn Thomas,Jose A. Cancelas,Catherine M. Bollard,Patrick J. Hanley,Michael D. Keller,Olivia Grimley,Diana Clark,Teri Clark,Cecilia S. Lindestam Arlehamn,Alessandro Sette,Stella M. Davies,Adam S. Nelson,Michael S. Grimley,Carolyn Lutzko
            
        
    
            
        
        Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Stéphane Buhler,Helen Baldomero,Sylvie Ferrari-Lacraz,Anne-Claire Mamez,Stavroula Masouridi-Levrat,Dominik Heim,Jörg Halter,Gayathri Nair,Yves Chalandon,Urs Schanz,Tayfun Güngör,Grazia Nicoloso,Jakob R. Passweg,Jean Villard,on behalf of the Swiss Blood Stem Cell Transplantation Group
            
        
    
            - 
        
            Cover Image
        
        
Cover Image
            Laser scanning confocal micrograph of a human plasma blood clot with fluorescently labeled fibrin. The plasma for this clot was from a volunteer with a high percentage of the fibrinogen splice variant fibrinogen γ′. An increased percentage of fibrinogen γ′ results in the formation of blood clots with denser fibrin networks that are harder to break down. See the article by Macrae et al.
 - PDF Icon Front MatterFront Matter
 - PDF Icon Editorial BoardEditorial Board
 
Advertisement intended for health care professionals
Advertisement intended for health care professionals
                    





















